A combination of a VEGF receptor antagonist and a histondeacetylase inhibitor is highly antitumoral effective in a rat hepatoma model

被引：0
|
作者：
Ganslmayer, M
Zimmermann, A
Ocker, M
Zopf, S
Schuppan, D
Hahn, EG
Herold, C
机构：
[1] Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
HEPATOLOGY | 2005年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：377A / 377A
页数：1
相关论文
共 50 条
  • [21] THE INHIBITOR CYTOKINE INTERLEUKIN-1 RECEPTOR ANTAGONIST SYNERGISTICALLY AUGMENTS CYCLOSPORINE IMMUNOSUPPRESSION IN A RAT CARDIAC ALLOGRAFT MODEL
    SHIRAISHI, M
    CSETE, M
    YASUNAGA, C
    MCDIARMID, SV
    VANNICE, JL
    BUSUTTIL, RW
    SHAKED, A
    JOURNAL OF SURGICAL RESEARCH, 1995, 58 (05) : 465 - 470
  • [22] Antitumoral effects of the Met inhibitor savolitinib in combination with durvalumab in a syngeneic small cell lung cancer mouse model
    Del Rey-Vergara, R.
    Galindo-Campos, M. A.
    Hardy-Werbin, M.
    Moliner, L.
    Rios-Hoyo, A.
    Martinez, C.
    Carpes, M.
    Gonzalez-Gallardo, S.
    Taus, A.
    Rovira, A.
    Arriola, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S724 - S725
  • [23] Combination of growth hormone receptor antagonist and gemcitabine leads to highly efficacious tumor clearance in a mouse model of pancreatic ductal adenocarcinoma
    Basu, Reetobrata
    Kulkarni, Prateek
    Davis, Emily
    Duran, Silvana
    Kopchick, John J.
    CANCER RESEARCH, 2022, 82 (12)
  • [24] Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
    W Fiskus
    S Sharma
    B Shah
    B P Portier
    S G T Devaraj
    K Liu
    S P Iyer
    D Bearss
    K N Bhalla
    Leukemia, 2014, 28 : 2155 - 2164
  • [25] Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
    Fiskus, W.
    Sharma, S.
    Shah, B.
    Portier, B. P.
    Devaraj, S. G. T.
    Liu, K.
    Iyer, S. P.
    Bearss, D.
    Bhalla, K. N.
    LEUKEMIA, 2014, 28 (11) : 2155 - 2164
  • [26] Effects of a converting enzyme inhibitor, an AT1-receptor antagonist and their combination on endothelial dysfunction in hypertension
    Goto, K
    Fujii, K
    Abe, I
    EDHF 2000, 2001, : 417 - 423
  • [27] Imaging of VEGF receptor in a rat myocardial infarction model using PET
    Rodriguez-Porcel, Martin
    Cai, Weibo
    Gheysens, Olivier
    Willmann, Juergen K.
    Chen, Kai
    Wang, Hui
    Chen, Ian Y.
    He, Lina
    Wu, Joseph C.
    Li, Zi-bo
    Mohamedali, Khalid A.
    Kim, Sehoon
    Rosenblum, Michael G.
    Chen, Xiaoyuan
    Gambhir, Sanjiv Sam
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (04) : 667 - 673
  • [28] Imazalil is an aryl hydrocarbon receptor (AhR) antagonist in AhR-dependent reporter human and rat hepatoma cells
    Van der Heiden, Edwige
    Bechoux, Nathalie
    Sergent, Therese
    Ribonnet, Laurence
    Schneider, Yves-Jacques
    Muller, Marc
    Pussemier, Luc
    Maghuin-Rogister, Guy
    Scippo, Marie-Louise
    TOXICOLOGY LETTERS, 2007, 172 : S203 - S204
  • [29] A combination of a transforming growth factor-β antagonist and an inhibitor of cyclooxygenase is an effective treatment for murine pulmonary tuberculosis
    Hernández-Pando, R
    Orozco-Esteves, H
    Maldonado, HA
    Aguilar-León, D
    Vilchis-Landeros, MM
    Mata-Espinosa, DA
    Mendoza, V
    López-Casillas, F
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 144 (02): : 264 - 272
  • [30] Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat
    McCafferty, Gerald P.
    Pullen, Mark A.
    Wu, Charlene
    Edwards, Richard M.
    Allen, Michael J.
    Woollard, Patrick M.
    Borthwick, Alan D.
    Liddle, John
    Hickey, Deirdre M. B.
    Brooks, David P.
    Westfall, Timothy D.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2007, 293 (01) : R299 - R305
12345